Skip to main navigation Skip to search Skip to main content

中国冠脉支架市场

Translated title of the contribution: The Coronary Stent Market in China
  • Wei Zhang (First Author)
  • , Leiping Xu (Participant Author)

Research output: Other contribution › Case Study

Abstract

Aiming to illustrate an innovation model in an emerging market, this case summarizes the successful launch of drug-eluting stents at MicroPort and the development of innovation capabilities and culture within the company. The case also demonstrates a strategic dilemma appearing after one round of effective technological innovation and, more importantly, how understanding the value system — in this case, the health care system — is key to sustaining innovation.
Translated title of the contributionThe Coronary Stent Market in China
Original languageChinese (Simplified)
Number of pages10
Publication statusPublished - 1 Jan 2012

Case number

GM-14-125

Case normative number

GM-14-125-CC

Case type

现场案例

Update date

2016-07-03

Published by

中欧国际工商学院

Keywords

  • 创新
  • 医疗保健
  • 战略
  • 经营模式

Case studies discipline

  • General Management
  • Strategy

Case studies industry

  • Health Care Services

OpenUrl availability

Full text

Fingerprint

Dive into the research topics of 'The Coronary Stent Market in China'. Together they form a unique fingerprint.
View full fingerprint

  • 微创医疗：从冠脉支架开始的征程

    Translated title of the contribution: MicroPort Scientific: An Odyssey Starting with Coronary StentsZhang, W. (First Author) & Xu, L. (Participant Author), 1 Jan 2012, 17 p.

    Research output: Other contribution › Case Study

Cite this